RAPP
Rapport Therapeutics Inc.
Company Overview
| Mkt Cap | $1.06B | Price | $28.93 |
| Volume | 415.30K | Change | +7.63% |
| P/E Ratio | -13.5 | Open | $26.77 |
| Revenue | -- | Prev Close | $26.88 |
| Net Income | $-78.3M | 52W Range | $6.43 - $42.27 |
| Div Yield | N/A | Target | $51.71 |
| Overall | 61 | Value | 60 |
| Quality | 44 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyRapport Therapeutics Inc. (RAPP) is a leading diversified company in the business industry, currently trading at $28.93 with a market capitalization of $1.06 billion. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows RAPP with a volume of 415K shares. The stock opened down 0.41% from yesterday's close of $26.88. Current analyst estimates project earnings of $-3.01 per share for this year, with next year targeting $-3.88.
RAPP demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for RAPP include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 78.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 06:44 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $28.93 | +7.6% | 415.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW